Please use this identifier to cite or link to this item: https://repository.monashhealth.org/monashhealthjspui/handle/1/36067
Full metadata record
DC FieldValueLanguage
dc.contributor.authorWareham N.J.en
dc.contributor.authorLong G.H.en
dc.contributor.authorHare M.J.L.en
dc.contributor.authorIrving G.en
dc.contributor.authorBoothby C.E.en
dc.contributor.authorGriffin S.J.en
dc.contributor.authorStrelitz J.en
dc.contributor.authorAhern A.L.en
dc.date.accessioned2021-05-14T12:13:14Zen
dc.date.available2021-05-14T12:13:14Zen
dc.date.copyright2019en
dc.date.created20190724en
dc.date.issued2019-07-24en
dc.identifier.citationDiabetologia. 62 (8) (pp 1391-1402), 2019. Date of Publication: 01 Aug 2019.en
dc.identifier.issn0012-186Xen
dc.identifier.urihttps://repository.monashhealth.org/monashhealthjspui/handle/1/36067en
dc.description.abstractAims/hypothesis: Adults with type 2 diabetes are at high risk of developing cardiovascular disease (CVD). Evidence of the impact of weight loss on incidence of CVD events among adults with diabetes is sparse and conflicting. We assessed weight change in the year following diabetes diagnosis and estimated associations with 10 year incidence of CVD events and all-cause mortality. Method(s): In a cohort analysis among 725 adults with screen-detected diabetes enrolled in the Anglo-Danish-Dutch Study of Intensive Treatment in People with Screen-Detected Diabetes in Primary Care (ADDITION)-Cambridge trial, we estimated HRs for weight change in the year following diabetes diagnosis and 10 year incidence of CVD (n = 99) and all-cause mortality (n = 95) using Cox proportional hazards regression. We used linear regression to estimate associations between weight loss and CVD risk factors. Models were adjusted for age, sex, baseline BMI, smoking, occupational socioeconomic status, cardio-protective medication use and treatment group. Result(s): Loss of >=5% body weight in the year following diabetes diagnosis was associated with improvements in HbA1c and blood lipids and a lower hazard of CVD at 10 years compared with maintaining weight (HR 0.52 [95% CI 0.32, 0.86]). The associations between weight gain vs weight maintenance and CVD (HR 0.41 [95% CI 0.15, 1.11]) and mortality (HR 1.63 [95% CI 0.83, 3.19]) were less clear. Conclusions/interpretation: Among adults with screen-detected diabetes, loss of >=5% body weight during the year after diagnosis was associated with a lower hazard of CVD events compared with maintaining weight. These results support the hypothesis that moderate weight loss may yield substantial long-term CVD reduction, and may be an achievable target outside of specialist-led behavioural treatment programmes.Copyright © 2019, The Author(s).en
dc.languageenen
dc.languageEnglishen
dc.publisherSpringer Verlag (E-mail: service@springer.de)en
dc.relation.ispartofDiabetologiaen
dc.titleModerate weight change following diabetes diagnosis and 10 year incidence of cardiovascular disease and mortality.en
dc.typeArticleen
dc.type.studyortrialObservational study (cohort, case-control, cross sectional or survey)-
dc.identifier.doihttp://monash.idm.oclc.org/login?url=http://dx.doi.org/10.1007/s00125-019-4886-1en
dc.publisher.placeGermanyen
dc.identifier.pubmedid31062041 [http://www.ncbi.nlm.nih.gov/pubmed/?term=31062041]en
dc.identifier.source627599806en
dc.identifier.institution(Strelitz, Ahern, Boothby, Wareham, Griffin) MRC Epidemiology Unit, Institute of Metabolic Science, Cambridge Biomedical Campus, University of Cambridge School of Clinical Medicine, Box 285, Cambridge CB2 0QQ, United Kingdom (Long) AstraZeneca Pharmaceuticals, Cambridge, United Kingdom (Hare) Departments of Endocrinology, Diabetes and Vascular Medicine, Monash Health, Melbourne, VIC, Australia (Irving, Griffin) Primary Care Unit, Institute of Public Health, University of Cambridge School of Clinical Medicine, Cambridge, United Kingdomen
dc.description.addressJ. Strelitz, MRC Epidemiology Unit, Institute of Metabolic Science, Cambridge Biomedical Campus, University of Cambridge School of Clinical Medicine, Box 285, Cambridge CB2 0QQ, United Kingdom. E-mail: jean.strelitz@mrc-epid.cam.ac.uken
dc.description.publicationstatusEmbaseen
dc.rights.statementCopyright 2019 Elsevier B.V., All rights reserved.en
dc.subect.keywordsCardiovascular disease Diabetes Epidemiology Weight lossen
dc.identifier.authoremailStrelitz J.; jean.strelitz@mrc-epid.cam.ac.uken
dc.description.grantNo: 08/116/300 Organization: (HTA) *Health Technology Assessment Programme* Organization No: 501100000664 Country: United Kingdom No: G061895 Organization: (WT) *Wellcome Trust* Organization No: 100010269 Country: United Kingdom No: MC_UU_12015/4 Organization: (MRC) *Medical Research Council* Organization No: 501100000265 Country: United Kingdom No: RP-PG-0606-1259 Organization: (PGfAR) *Programme Grants for Applied Research* Organization No: 501100007602 Country: United Kingdomen
item.fulltextNo Fulltext-
item.cerifentitytypePublications-
item.openairecristypehttp://purl.org/coar/resource_type/c_18cf-
item.grantfulltextnone-
item.openairetypeArticle-
Appears in Collections:Articles
Show simple item record

Page view(s)

60
checked on Feb 6, 2025

Google ScholarTM

Check


Items in Monash Health Research Repository are protected by copyright, with all rights reserved, unless otherwise indicated.